{
    "SPADE_N_15237": {
        "Sequence Information": {
            "Peptide Name": "Malformin A1",
            "Sequence": "CCVLI",
            "Sequence Length": 5,
            "Biological Activity": [
                "Antiparasitic",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Mitochondrial membrane",
            "Source": "1. Aspergillus niger\n2. Aspergillus tubingensis",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Malformin A1 promotes cell death through induction of apoptosis, necrosis and autophagy in prostate cancer cells.",
                    "Pubmed ID": "26645406",
                    "Reference": "Cancer Chemother Pharmacol. 2016;77:63-75",
                    "Author": "Liu Y, Wang M, Wang D, Li X, Wang W, Lou H, Yuan H",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/26645406"
                },
                {
                    "Title": "Trypanocidal activity, cytotoxicity and histone modifications induced by malformin A1 isolated from the marine-derived fungus Aspergillus tubingensis IFM 63452",
                    "Pubmed ID": "",
                    "Reference": "Mycosphere. 2017;8:Mycosphere 8(1): 111–120 (2017)",
                    "Author": "Notarte KI, Nakao Y, Yaguchi T, Bungihan M, Suganuma K, dela Cruz TE",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"
                },
                {
                    "Title": "Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis.",
                    "Pubmed ID": "34199287",
                    "Reference": "Molecules. 2021;26:3624",
                    "Author": "Abdullah N, Tamimi Y, Dobretsov S, Balushi NA, Alshekaili J, Al Balushi H, Al Kindi M, Hassan SI, Bahlani SA, Tsang BK, Burney IA",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/34199287"
                },
                {
                    "Title": "Structure-activity relationship of cyclic pentapeptide malformins as fibrinolysis enhancers.",
                    "Pubmed ID": "27680590",
                    "Reference": "Bioorg Med Chem Lett. 2016;26:5267-5271",
                    "Author": "Koizumi Y, Nagai K, Hasumi K, Kuba K, Sugiyama T",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/27680590"
                }
            ],
            "Mass": 549.75,
            "PI": 5.51,
            "Net Charge": 0,
            "Hydrophobicity": 3.5,
            "Frequent Amino Acids": "CIL",
            "Absent Amino Acids": "ADEFGHKMNOPQRSTUWY",
            "Basic Residues": 0,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 5,
            "Polar Residues": 0,
            "Positive Residues": 0,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_N_15237",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_00511",
                    "Similarity": 1.0,
                    "Sequence": "SDSFPGLGLKKQAHKQCYSPDLCTGGDSKCDICCVLISGVYYGKCIQSKCHCLNKTK"
                },
                {
                    "SPADE_ID": "SPADE_N_02857",
                    "Similarity": 1.0,
                    "Sequence": "GMKEKCVTMGGYCRKQCRVQDALSGYCRNENPCCV"
                },
                {
                    "SPADE_ID": "SPADE_N_03703",
                    "Similarity": 1.0,
                    "Sequence": "KKCANTLGNCRKMCRDGEKQTEPATSKCPIGKLCCVL"
                }
            ],
            "Hemolytic Activity": "Human normal ovarian cells HOSE3-6:IC50=0.07",
            "Target Organism": "Human prostate adenocarcinoma PC-3(IC50=0.13µM),Human prostate adenocarcinoma LNCaP(IC50=0.09µM),Trypanosoma congolense(IC50=0.01508µg/ml),Human cervical carcinoma HeLa(IC50=0.05015µg/ml),Mouse lymphoma cells P388(IC50=0.07038µg/ml),Human ovarian adenocarcinoma A2780(IC50=0.23µM),Human ovarian adenocarcinoma A2780CisR(IC50=0.34µM),Human histiocytic lymphoma U-937(IC50=0.80µM)"
        }
    }
}